Charles M. Rudin

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

Charles M. Rudin

Nov 10, 2024, 14:58 | Blog

Pancreatic adenocarcinoma to develop unique mitochondrial subpopulations under stress

Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared following post on LinkedIn: ''Study…

Oct 12, 2024, 22:16 | Insight

Triparna Sen: CD38-mediated immunosuppression as a potential mechanism of tumor cell escape from PDL1 inhibition in SCLC

Triparna Sen, Associate Professor, Icahn School of Medicine at Mount Sinai, shared a post on…

Jul 26, 2024, 00:16 | Insight

Impact of the intratumoral microbiome of NSCLC on outcomes with immunotherapy

Stephen Liu shared on X: "Impressive work on impact of the intratumoral microbiome of NSCLC…

Jul 25, 2024, 00:32 | Blog

Jarushka Naidoo: Can intratumor eschericia improve OS from ICIs in NSCLC

Jarushka Naidoo shared a post on X: ''Can intratumor eschericia (E) bring immune cells to…

Apr 26, 2024, 20:26 | Insight

New Paper Alert! Liposomal Irinotecan vs Topotecan for Relapsed Small Cell Lung Cancer: RESILIENT Phase 3 Trial

Liposomal Irinotecan vs Topotecan for Relapsed Small Cell Lung Cancer: RESILIENT Phase 3 Trial Authors:…

All: 5 Posts: 1 - 100

Dr. Richard Pazdur's 25 Year WAR on Cancer at the FDA!

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023